Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/25/2003WO2003078613A2 Serine hydroxymethyltransferase as a target for herbicides
09/25/2003WO2003078609A1 Methods of inducing differentiation of stem cells into a specific cell lineage
09/25/2003WO2003078608A1 Methods of inducing differentiation of stem cells into a specific cell lineage
09/25/2003WO2003078604A2 Tobacco rattle virus vectors and related compositions and methods
09/25/2003WO2003078600A2 Human monoclonal antibodies to influenza m2 protein and methods of making and using same
09/25/2003WO2003078592A2 Method for the purification, production and formulation of oncolytic adenoviruses
09/25/2003WO2003078591A2 Cell division and proliferation preferred regulatory elements and uses thereof
09/25/2003WO2003078590A2 Early inflorescence-preferred regulatory elements and uses thereof
09/25/2003WO2003078589A2 Method of identifying genes controlling diferentiation
09/25/2003WO2003078580A2 Imprinting in plants to control gene expression
09/25/2003WO2003078577A2 Cloning of cytochrome p450 genes from nicotiana
09/25/2003WO2003078576A2 Vector for transfection of eukaryotic cells
09/25/2003WO2003078575A2 Molecular switches and methods for making and using the same
09/25/2003WO2003078570A2 Multiple controls for molecular genetic analyses
09/25/2003WO2003078568A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
09/25/2003WO2003078469A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
09/25/2003WO2003078466A1 Novel g protein-coupled recepotrs and genes thereof
09/25/2003WO2003078463A1 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy
09/25/2003WO2003078460A1 Peptides, medicinal compositions containing the peptide and medicinal compositions for treating cancer
09/25/2003WO2003078458A2 Tap-70, a novel marker for epithelial tumors
09/25/2003WO2003078457A1 MUTEINS OF THE C5a ANAPHYLATOXIN, NUCLEIC ACID MOLECULES ENCODING SUCH MUTEINS, AND PHARMACEUTICAL USES OF MUTEINS OF THE C5a ANAPHYLATOXIN
09/25/2003WO2003078453A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
09/25/2003WO2003078451A2 Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby
09/25/2003WO2003078449A2 A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins
09/25/2003WO2003078446A2 A building block forming a c-c or a c-hetero atom bond upon reaction
09/25/2003WO2003078445A2 A building block forming a c=c double bond upon reaction
09/25/2003WO2003078383A1 Novel positively charged lipids and liposomes comprising the positively charged lipids
09/25/2003WO2003078050A2 A building block forming a c-c bond upon reaction
09/25/2003WO2003077947A1 Methods of modulating cd200 receptors
09/25/2003WO2003077875A2 Proteins associated with growth, differentiation, and death
09/25/2003WO2003077868A2 Synthesis of synthons for the manufacture of bioactive compounds
09/25/2003WO2003077863A2 Method for overexpression of zwitterionic polysaccharides
09/25/2003WO2003077859A2 Method of inducing an enhanced immune response against hiv
09/25/2003WO2003077852A2 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β
09/25/2003WO2003077848A2 Jagged 2 inhibitors for inducing apoptosis
09/25/2003WO2003077844A2 Effect of treatment with 4,5-dihydroxy- 2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria
09/25/2003WO2003077836A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/25/2003WO2003077653A1 Autoinducer compounds
09/25/2003WO2003077648A2 Methods for the identification of herbicides and the modulation of plant growth
09/25/2003WO2003077643A2 Methods for increasing the oil content in plants by reducing the content of one or more storage proteins
09/25/2003WO2003067251A3 Device for performing cell assays
09/25/2003WO2003060101A3 Gene delivery system and methods of use
09/25/2003WO2003052118A3 Bgl4 beta-glucosidase and nucleic acids encoding the same
09/25/2003WO2003050278A3 Stabilisation of double-stranded nucleic acids using proteins
09/25/2003WO2003044197A9 Huntington’s disease gene transcriptional factors
09/25/2003WO2003042411A3 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
09/25/2003WO2003042402A3 Agents that modulate immune cell activation and methods of use thereof
09/25/2003WO2003042246A3 Inhibitors of the notch signalling pathway for use in the treatment of cancer
09/25/2003WO2003042245B1 Growth hormone variations in humans and their uses
09/25/2003WO2003040368A3 Pharmaceutical compositions of marine sponge microciona prolifera
09/25/2003WO2003040313A3 Il-21 antagonists
09/25/2003WO2003040295A3 Ion channel
09/25/2003WO2003038724A9 Methods and apparatus for protein sequence analysis
09/25/2003WO2003038041A3 Il-4 mutein proteins, antibodies, compositions, methods and uses
09/25/2003WO2003035879A3 Promoters to control cell differentiation
09/25/2003WO2003035682A3 Peptides and protins binding to glu-pro motidfs, therapeutical compositions containing them and their applications
09/25/2003WO2003033740A3 Apparatus and method for isolating a nucleic acid
09/25/2003WO2003033699A3 Production, detection and use of transformant cells
09/25/2003WO2003033519A3 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
09/25/2003WO2003031470A3 Dna-expression construct for treatment of infections with leishmaniasis
09/25/2003WO2003029476A3 Process for the preparation of d-pantothenic acid and/or its salts
09/25/2003WO2003026394A3 Cathepsin g (ctsg) disruptions, compositions and methods relating thereto
09/25/2003WO2003025181A3 Dna sequences that encode variable regions of antibodies that bind to the prion protein (prp), and prp-binding polypeptides
09/25/2003WO2003022988A3 Adipose-derived stem cells and lattices
09/25/2003WO2003020885A3 Identification of sortase gene
09/25/2003WO2003016521A3 Aav vector packaging plasmid for producing wtaav particles or pseudotyped aav particles without helper viruses, by means of a single transfection
09/25/2003WO2003016343A3 USE OF αCP1, αCP2, AND HUR FOR MODULATING GENE EXPRESSION AND INDUCING ANGIOGENESIS
09/25/2003WO2003013537A3 Irinotecan for treatment of cancer
09/25/2003WO2003013535A3 Use of irinotecan for improved treatment of cancer based on mdr1
09/25/2003WO2003012136A3 Method to detect splice variants of the calcineurin gene
09/25/2003WO2003012078A3 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
09/25/2003WO2003011331A3 Materials and methods relating to improved vaccination strategies
09/25/2003WO2003008596A3 Expression cassettes for transgenically expressing selection markers
09/25/2003WO2003008454A3 Glycoprotein vi fusion proteins
09/25/2003WO2003006047A3 Methods for reducing immunogenicity of polypeptides
09/25/2003WO2003004659A3 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms
09/25/2003WO2003004627A3 Novel human hepatoma lines, methods for obtaining same and uses thereof
09/25/2003WO2003002114A3 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
09/25/2003WO2003000907A3 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation
09/25/2003WO2003000737A3 MOUSE μ LIGHT CHAIN LOCUS
09/25/2003WO2002103043A3 Method for the specific fast detection of bacteria which is harmful to beer
09/25/2003WO2002102824A3 Method for specific fast detection of relevant bacteria in drinking water
09/25/2003WO2002100998A3 Method for generating diversity
09/25/2003WO2002100884A3 Cloned mammalian polyamine oxidase
09/25/2003WO2002100827A9 Method for increasing the survival of dopamine secreting cells
09/25/2003WO2002097081A3 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production
09/25/2003WO2002097059A9 Chromosome-based platforms
09/25/2003WO2002097049A3 Compositions and methods for binding agglomeration proteins
09/25/2003WO2002092826A3 Composition and method for treating cancer using herpes virus
09/25/2003WO2002092635A3 Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
09/25/2003WO2002092628A3 Plasmodium falciparum antigens and vaccine and diagnostic uses thereof
09/25/2003WO2002090584A3 Method for labelling and fragmenting dna
09/25/2003WO2002088736A3 Prenatal diagnosis method on isolated foetal cell of maternal blood
09/25/2003WO2002088370A3 Autogene nucleic acids encoding a secretable rna polymerase
09/25/2003WO2002082086A3 Detection of methicillin-resistant staphylococcus aureus (mrsa)
09/25/2003WO2002081705A3 Regulation of human gnat acetyltransferase-like protein
09/25/2003WO2002080847A3 Use of tumor necrosis factor inhibitors to treat cardiovascular disease
09/25/2003WO2002077263A3 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
09/25/2003WO2002074920A3 A replication-defective alphavirus vaccine linking antigen with an immunogenicity-potentiating polypeptide and a method of delivery the same
09/25/2003WO2002074078A3 Method for embryo after impregnation of the recipient female